{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":14,"n_cols":5,"rows_kept":14,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[11,2,11,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910880295703321"]
[null,null,"Autore",null,"Berger Stephen"]
[null,null,"Titolo",null,"Rift Valley Fever"]
[null,null,"Pubbl/distr/stampa",null,"Los Angeles : , : Gideon Informatics, Incorporated, , 2024"]
[{"$nulls":4},"©2024"]
[null,null,"ISBN",null,"1-4988-4625-4"]
[null,null,"Edizione",null,"[2024th ed.]"]
[null,null,"Descrizione fisica",null,"1 online resource (71 pages)"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,"Nota di contenuto",null,"Intro -- Copyright -- Introduction: The GIDEON e-book series -- Table of Contents -- Rift Valley fever -- Epidemiology -- Agent -- Reservoir -- Vector -- Vehicle -- Incubation Period -- Diagnostic Tests -- Typical Adult Therapy -- Typical Pediatric Therapy -- Vaccine -- Clinical Hints -- Synonyms -- References -- Clinical -- References -- Distribution Map -- Images -- Global status -- References -- Bioterrorism -- References -- Algeria -- References -- Angola -- References -- Belgium -- Botswana -- References -- Burkina Faso -- References -- Burundi -- References -- Cameroon -- References -- Canada -- References -- The Canary Islands -- References -- Central African Republic -- References -- Chad -- References -- China -- References -- The Comoros and Mayotte -- References -- Croatia -- The Czech Republic -- The Democratic Republic of Congo -- References -- Djibouti -- References -- Egypt -- References -- Estonia -- Eswatini -- References -- Ethiopia -- References -- France -- References -- Gabon -- References -- Gambia -- References -- Germany -- References -- Ghana -- References -- Guinea -- References -- Hungary -- Iran -- References -- Ireland -- Israel -- References -- Italy -- References -- Ivory Coast -- References -- Japan -- References -- Jordan -- References -- Kenya -- References -- Latvia -- Libya -- References -- Lithuania -- Luxembourg -- Madagascar -- References -- Malawi -- References -- Mali -- References -- Malta -- Mauritania -- References -- Morocco -- References -- Mozambique -- References -- Namibia -- References -- The Netherlands -- References -- Niger -- References -- Nigeria -- References -- Norway -- Poland -- Qatar -- References -- South Korea "]
[{"$nulls":4},"-- References -- Romania -- Rwanda -- References -- Saudi Arabia -- References -- Senegal -- References -- Sierra Leone -- References -- Slovakia -- Slovenia -- Somalia."]
[{"$nulls":4},"References -- South Africa -- References -- South Sudan -- References -- Spain -- References -- Sudan -- References -- Sweden -- References -- Taiwan -- Tanzania -- References -- Tunisia -- References -- Turkey -- References -- Uganda -- References -- The United Kingdom -- References -- The United States -- References -- Western Sahara -- References -- Yemen -- References -- Zambia -- References -- Zimbabwe -- References -- Vaccines &amp -- Immunoglobulins -- Rift Valley fever vaccine -- Mechanism of Action -- Typical Adult Dosage -- Typical Pediatric Dosage -- Subsequent booster -- Toxic Effects for Rift Valley fever vaccine (0 listed) -- Contraindications for Rift Valley fever vaccine (2 listed) -- Trade names of Rift Valley fever vaccine (0 listed) -- About GIDEON."]